Ying Peng

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Tandem Mass Spectrometry

Prostate Cancer

Top Venues

Rapid communications in mass spectrometry : RCM

Food & function

This page only lists publications with an associated author ORCID identifier.

Publications

Qingqing Wang, Zihou Liu, Rui Wang, Run Li, Xiaoru Lian, Yanquan Yang, Jiao Yan, Zhi-Qi Yin, Guangji Wang, Jianguo Sun, Ying Peng
Effect of Ginkgo biloba extract on pharmacology and pharmacokinetics of atorvastatin in rats with hyperlipidaemia. Food & function (2023)
Jing Zhang, Ran Zhang, Ying Peng, Jiye Aa, Guangji Wang
AI Machine Learning Technique Characterizes Potential Markers of Depression in Two Animal Models of Depression. Brain sciences 13 (5) (2023)
Yue Gu, Mengxia Xue, Qizhi Wang, Xiaodan Hong, Xinyu Wang, Fang Zhou, Jianguo Sun, Guangji Wang, Ying Peng
Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis. International journal of molecular sciences 22 (24) (2021)
Feng Qu, Yue Gu, Mengxia Xue, Mingzhe He, Fang Zhou, Guangji Wang, Ying Peng
Impact of therapy on cancer metabolism in high-risk localized prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy. The Prostate 81 (9) (2021)
Hua Sang, Yu Wang, Yunxi Zhong, Shiyin Gu, Guangji Wang, Jianguo Sun, Ying Peng
Quantitative determination of proxalutamide in rat plasma and tissues using liquid chromatography/tandem mass spectrometry. Rapid communications in mass spectrometry : RCM 35 (3) (2021)
Feng Qu, Yue Gu, Qizhi Wang, Mingzhe He, Fang Zhou, Jianguo Sun, Guangji Wang, Ying Peng
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells. Investigational new drugs 38 (5) (2020)